Bedaquiline-a potential inhibitor of COVID-19 main protease based on molecular docking. Int. J. of Res. in Pharmacology &Pharmacotherapeutics . 2021;9(2):136-144. doi:10.61096/ijrpp.v9.iss2.2020.136-144